药价虚高的原因及治理对策

发布时间：2018-03-30 10:41

  本文选题：会计监督　切入点：医药行业　出处：《中国财政》2015年10期

【摘要】：正现阶段,我国药品价格虚高的问题是全社会普遍关注的焦点之一,不仅加重老百姓的经济负担,助长腐败影响社会公正,而且严重扰乱了制药行业的健康科学发展。为切实履行好财政部门会计监督职责,按照财政部统一部署,近期河北专员办在开展医药行业会计监督专项检查中,选取重点药品从生产、流通、使用等各环节进行了全面调研,旨在揭示药品在各环节的加价和成本利润构成现状,研究药价形成机制,提出治理药价虚高的政策建议。
[Abstract]:At the present stage, the problem of false drug prices in our country is one of the focuses of the whole society. It not only increases the economic burden of the common people, but also encourages corruption and affects social justice. Moreover, it has seriously disturbed the healthy and scientific development of the pharmaceutical industry. In order to effectively perform the accounting supervision duties of the financial sector, and in accordance with the unified arrangements of the Ministry of Finance, the Hebei Commissioner's Office recently conducted a special inspection of accounting supervision in the pharmaceutical industry. In order to reveal the current situation of drug price increase and cost profit composition, to study the mechanism of drug price formation, and to put forward some policy suggestions on how to control the false drug price, this paper selects the key drugs from production, circulation, use and other links to carry on a comprehensive investigation.
【作者单位】： 财政部驻河北省财政监察专员办事处;
【分类号】：R95
，

本文编号：1685569